article thumbnail

Reinventing Life Science Startups–Therapeutics and Diagnostics

Steve Blank

has gone offshore primarily due to the toughened regulatory environment. It has gotten so bad that pension funds and other institutional investors in venture capital funds have told these funds to stay away from Life Science – or at the least, early stage Life Science. Pharma companies are staggering under the costs.

article thumbnail

How Venture Capitalists and Government Can Promote Entrepreneurship

David Teten

This is effectively a sequel to my study of best practices in deal origination , published last year in the Journal of Private Equity , Harvard Business Review , Institutional Investor , and Business Insider. A team in California is already creating a offshore seastead for non-US citizens who want to build companies in the US.

article thumbnail

Why So Many Small Emerging Managers Don’t Use Placement Agents

David Teten

They had 154 visits, 97 due diligence requests, 33 second visits, and 12 reference requests, to ultimately produce 9 institutional investors. Another option is to use an online investor ecosystem. For example, Backstage Capital recently used Republic to raise $4,856,800 from 7,021 investors in one day. .